Source: Annual Congress 2005 - Highlights of the 2005 ERS Lung Science Conference in Taormina
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Dimitropoulou (Augusta, United States of America). Estrogen requires the NO-cGMP-PKG pathway in order to prevent the hyper-responsiveness of asthmatic tracheal smooth muscle to carbachol. Annual Congress 2005 - Highlights of the 2005 ERS Lung Science Conference in Taormina

Member's Comments

No comment yet.

Related content which might interest you: Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism Source: International Congress 2017 – Novel mechanisms and treatments for asthma Year: 2017 Regulation of airway smooth muscle RhoA/ROCK activities by cholinergic and bronchodilator stimuli Source: Eur Respir J 2006 Oct 01;28(4):703-711 Year: 2006 Mechanisms of bronchial hyperresponsiveness in a clinical setting – putative role of smooth muscle Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease Year: 2005 Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Inhibition of IgE-induced airway smooth muscle cell constriction by the anti-IgE-antibody omalizumab Source: Annual Congress 2008 - Airway cell biology and immunology Year: 2008 Beta2-agonists but not glucocorticoids inhibit proliferation of asthmatic airway smooth muscle cells Source: Eur Respir J 2004; 24: Suppl. 48, 251s Year: 2004 Serelaxin is a potent inhibitor of airway contraction and enhances β-adrenoceptor-mediated relaxation Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Epac1 and Epac2 regulate airway smooth muscle tone in mice Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Rhinovirus-induced IL-33 expression in asthmatic airway smooth muscle cells is TLR3-dependent and involves activation of TAK1 Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 Role of bronchial smooth muscle mitochondria in airway remodeling in asthma Source: Eur Respir J 2007; 30: Suppl. 51, 286s Year: 2007 TLR3/TAK1 signalling regulates rhinovirus-induced interleukin-33 in bronchial smooth muscle cells Source: ERJ Open Res, 6 (4) 00147-2020; 10.1183/23120541.00147-2020 Year: 2020 Airway hyperresponsiveness development is related to airway smooth muscle cytosolic β1 integrin subunit expressing cells Source: Annual Congress 2010 - Airway smooth muscle cells Year: 2010 Role of apoptosis in airway smooth muscle remodeling in experimental asthma Source: Eur Respir J 2007; 30: Suppl. 51, 369s Year: 2007 Functional Wnt signalling in airway smooth muscle from asthma patients Source: Annual Congress 2010 - Airway smooth muscle cells Year: 2010 Raised airway CO2 relaxes bronchial smooth muscle and diminishes methacholine induced bronchoconstriction Source: Eur Respir J 2001; 18: Suppl. 33, 253s Year: 2001 Intrinsic tone in human airway smooth muscle increases subsequent contractile response Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Mechanisms of airway smooth muscle reactivity in an allergen-induced asthmatic reaction in rats Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Relaxation of tracheal smooth muscle is impaired in innate airway hyperresponsiveness Source: Eur Respir J 2009; 33: 417-424 Year: 2009 Tocotrienol inhibits TGF-beta1-induced human airway smooth muscle cell differentiation Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Nonspecific airway hyperresponsiveness is associated with prolonged relaxation of isolated tracheal smooth muscle in rats Source: Eur Respir J 2001; 18: Suppl. 33, 32s Year: 2001